BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 85 filers reported holding BEAM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $837,181 | -20.3% | 34,810 | +5.8% | 0.01% | -16.7% |
Q2 2023 | $1,050,273 | +11.8% | 32,893 | +7.2% | 0.01% | 0.0% |
Q1 2023 | $939,238 | -20.1% | 30,674 | +2.0% | 0.01% | -25.0% |
Q4 2022 | $1,175,803 | -18.2% | 30,064 | -0.4% | 0.01% | -20.0% |
Q3 2022 | $1,437,000 | +24.7% | 30,174 | +1.4% | 0.01% | +25.0% |
Q2 2022 | $1,152,000 | -20.9% | 29,748 | +17.1% | 0.01% | 0.0% |
Q1 2022 | $1,456,000 | -32.8% | 25,414 | -6.6% | 0.01% | -27.3% |
Q4 2021 | $2,168,000 | -8.7% | 27,203 | -0.3% | 0.01% | -15.4% |
Q3 2021 | $2,374,000 | -29.9% | 27,283 | +3.6% | 0.01% | +18.2% |
Q2 2021 | $3,388,000 | +82.1% | 26,325 | +13.2% | 0.01% | +57.1% |
Q1 2021 | $1,861,000 | -1.7% | 23,254 | +0.3% | 0.01% | 0.0% |
Q4 2020 | $1,893,000 | +264.0% | 23,193 | +9.8% | 0.01% | +250.0% |
Q3 2020 | $520,000 | +146.4% | 21,131 | +180.5% | 0.00% | +100.0% |
Q2 2020 | $211,000 | +61.1% | 7,532 | +3.6% | 0.00% | 0.0% |
Q1 2020 | $131,000 | – | 7,271 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |